Literature DB >> 18194653

Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.

Jing Li1, Cong Ran, Edward Li, Faye Gordon, Grant Comstock, Hasan Siddiqui, Whitney Cleghorn, Hui-Zi Chen, Karl Kornacker, Chang-Gong Liu, Shusil K Pandit, Mehrbod Khanizadeh, Michael Weinstein, Gustavo Leone, Alain de Bruin.   

Abstract

The E2f7 and E2f8 family members are thought to function as transcriptional repressors important for the control of cell proliferation. Here, we have analyzed the consequences of inactivating E2f7 and E2f8 in mice and show that their individual loss had no significant effect on development. Their combined ablation, however, resulted in massive apoptosis and dilation of blood vessels, culminating in lethality by embryonic day E11.5. A deficiency in E2f7 and E2f8 led to an increase in E2f1 and p53, as well as in many stress-related genes. Homo- and heterodimers of E2F7 and E2F8 were found on target promoters, including E2f1. Importantly, loss of either E2f1 or p53 suppressed the massive apoptosis in double-mutant embryos. These results identify E2F7 and E2F8 as a unique repressive arm of the E2F transcriptional network that is critical for embryonic development and control of the E2F1-p53 apoptotic axis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194653      PMCID: PMC2253677          DOI: 10.1016/j.devcel.2007.10.017

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  44 in total

1.  A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription.

Authors:  Paloma H Giangrande; Wencheng Zhu; Susanne Schlisio; Xin Sun; Seiichi Mori; Stefan Gaubatz; Joseph R Nevins
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

Review 2.  The E2F family: specific functions and overlapping interests.

Authors:  Claire Attwooll; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

Review 3.  The E2F transcriptional network: old acquaintances with new faces.

Authors:  Desssislava K Dimova; Nicholas J Dyson
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

4.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

Authors:  M Lakso; J G Pichel; J R Gorman; B Sauer; Y Okamoto; E Lee; F W Alt; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  E2F-1 functions in mice to promote apoptosis and suppress proliferation.

Authors:  S J Field; F Y Tsai; F Kuo; A M Zubiaga; W G Kaelin; D M Livingston; S H Orkin; M E Greenberg
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

6.  Tumor induction and tissue atrophy in mice lacking E2F-1.

Authors:  L Yamasaki; T Jacks; R Bronson; E Goillot; E Harlow; N J Dyson
Journal:  Cell       Date:  1996-05-17       Impact factor: 41.582

7.  E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

Authors:  G Leone; J DeGregori; Z Yan; L Jakoi; S Ishida; R S Williams; J R Nevins
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

8.  A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting.

Authors:  G J Lindeman; L Dagnino; S Gaubatz; Y Xu; R T Bronson; H B Warren; D M Livingston
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

9.  Distinct roles for E2F proteins in cell growth control and apoptosis.

Authors:  J DeGregori; G Leone; A Miron; L Jakoi; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

10.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

View more
  105 in total

1.  Atypical E2F activity coordinates PHR1 photolyase gene transcription with endoreduplication onset.

Authors:  Amandine Radziejwoski; Kobe Vlieghe; Tim Lammens; Barbara Berckmans; Sara Maes; Marcel A K Jansen; Claudia Knappe; Andreas Albert; Harald K Seidlitz; Günther Bahnweg; Dirk Inzé; Lieven De Veylder
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

2.  Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.

Authors:  Michiel Boekhout; Ruixue Yuan; Annelotte P Wondergem; Hendrika A Segeren; Elsbeth A van Liere; Nesibu Awol; Imke Jansen; Rob M F Wolthuis; Alain de Bruin; Bart Westendorp
Journal:  EMBO Rep       Date:  2016-02-05       Impact factor: 8.807

3.  Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation.

Authors:  Maria C Cuitiño; Thierry Pécot; Daokun Sun; Raleigh Kladney; Takayuki Okano-Uchida; Neelam Shinde; Resham Saeed; Antonio J Perez-Castro; Amy Webb; Tom Liu; Soo In Bae; Linda Clijsters; Nicholas Selner; Vincenzo Coppola; Cynthia Timmers; Michael C Ostrowski; Michele Pagano; Gustavo Leone
Journal:  Cell Rep       Date:  2019-05-23       Impact factor: 9.423

4.  Rapid temporal dynamics of transcription, protein synthesis, and secretion during macrophage activation.

Authors:  Katrin Eichelbaum; Jeroen Krijgsveld
Journal:  Mol Cell Proteomics       Date:  2014-01-06       Impact factor: 5.911

5.  Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.

Authors:  Beiyu Liu; Igor Shats; Steven P Angus; Michael L Gatza; Joseph R Nevins
Journal:  J Biol Chem       Date:  2013-07-13       Impact factor: 5.157

6.  Targeting Rb inactivation in cancers by synthetic lethality.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Am J Cancer Res       Date:  2011-06-30       Impact factor: 6.166

7.  Overexpression of stathmin 1 confers an independent prognostic indicator in nasopharyngeal carcinoma.

Authors:  Han-Ping Hsu; Chien-Feng Li; Sung-Wei Lee; Wen-Ren Wu; Tzu-Ju Chen; Kwang-Yu Chang; Shih-Shin Liang; Chia-Jung Tsai; Yow-Ling Shiue
Journal:  Tumour Biol       Date:  2013-11-12

Review 8.  p53 and E2f: partners in life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

Review 9.  The rb pathway and cancer therapeutics.

Authors:  W Du; J S Searle
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

10.  E2F8 is essential for polyploidization in mammalian cells.

Authors:  Shusil K Pandit; Bart Westendorp; Sathidpak Nantasanti; Elsbeth van Liere; Peter C J Tooten; Peter W A Cornelissen; Mathilda J M Toussaint; Wouter H Lamers; Alain de Bruin
Journal:  Nat Cell Biol       Date:  2012-10-14       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.